Get the Stockscreener App
13.46
7.34%
0.92
After Hours:
13.23
-0.23
-1.71%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $13.46, with a volume of 810.81K.
It is up +7.34% in the last 24 hours and up +37.49% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$12.54
Open:
$13.235
24h Volume:
810.81K
Relative Volume:
1.15
Market Cap:
$613.02M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-25.88
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
+13.87%
1M Performance:
+37.49%
6M Performance:
-28.02%
1Y Performance:
+42.43%
1-Day Range:
$13.20
$13.65
1-Week Range:
$11.25
$13.65
52-Week Range:
$7.34
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
13.46 | 571.12M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen, Inc.'s (NASDAQ:AXGN) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st
Axogen Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 - GlobeNewswire
Arizona State Retirement System Makes New $222,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Is Axogen Inc. a good long term investmentExtraordinary profit generation - jammulinksnews.com
Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 - Quiver Quantitative
What analysts say about Axogen Inc. stockAccelerated investment success - jammulinksnews.com
Why Axogen Inc. stock attracts strong analyst attentionFree AI-Powered Stock Predictions - Newser
What drives Axogen Inc. stock pricePhenomenal investment performance - jammulinksnews.com
Leerink Partnrs Brokers Lower Earnings Estimates for AxoGen - Defense World
Leerink Partnrs Has Pessimistic View of AxoGen Q4 Earnings - Defense World
why axogen inc. stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser
How Axogen Inc. stock performs during market volatilityFree Premium Stock Market Reports - Newser
What makes Axogen Inc. stock price move sharplyInvestor Favorite Picks - Newser
How To Trade (AXGN) - news.stocktradersdaily.com
Axogen (NASDAQ:AXGN) swells 10% this week, taking three-year gains to 46% - simplywall.st
AxoGen’s SWOT analysis: nerve repair leader’s stock poised for growth By Investing.com - Investing.com India
Learn to Evaluate (AXGN) using the Charts - news.stocktradersdaily.com
Axogen Showcases Nerve Repair Vision at Goldman Sachs - Yahoo Finance
Axogen, Inc. (NASDAQ:AXGN) Is Expected To Breakeven In The Near Future - 富途牛牛
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Long Term Trading Analysis for (AXGN) - news.stocktradersdaily.com
SG Americas Securities LLC Has $704,000 Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by Rhumbline Advisers - Defense World
Institutional investors in Axogen, Inc. (NASDAQ:AXGN) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
AxoGen at Goldman Sachs Conference: Strategic Path to Nerve Repair Growth - Investing.com Canada
Transcript : Axogen, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):